“The rating action reflects our view of ProMedica’s expected weaker operating performance over the next couple of years and an expectation of potentially lighter-than-historical margins over the medium term,” said S&P analyst Suzie Desai.
The outlook is stable, reflecting S&P’s view of ProMedica’s leading business position and ongoing strategic investments.
More articles on healthcare finance:
Local council approves refinancing plan for Wagoner Community Hospital
5 must-reads on RCM improvement
This week’s 5 must-reads for hospital CFOs
